Literature DB >> 2495328

Transcriptional control of MHC class II gene expression during differentiation from B cells to plasma cells.

P Dellabona1, F Latron, A Maffei, L Scarpellino, R S Accolla.   

Abstract

In this study we investigated the molecular mechanisms responsible for the extinction of the constitutive MHC class II gene expression of human B cells on somatic cell hybridization with murine plasmocytoma cells. We found that this event is due to trans-acting suppressor functions of mouse origin pre-existing in the plasmocytoma cells and acting at transcriptional level. Transcription of the entire family of human class II genes is suppressed, including genes as DO beta for which a distinct regulation of expression in B cells had been previously demonstrated. Suppression appears specific for class II genes because in the hybrids expression of MHC class I genes of mouse is unaffected and of human only partially reduced. Interestingly, also murine invariant chain gene is expressed in both parental plasmocytoma and hybrid cells although at reduced amounts as compared to a murine class II positive B cell line. The class II negative phenotype of hybrid cells and parental plasmocytoma cells is highly stable and unaffected by treatment with protein synthesis inhibitors, suggesting that the transcriptional suppressor function is not mediated by rapid, labile turning-over proteins. Possible mechanisms responsible for transcriptional regulation of MHC class II gene expression during terminal differentiation of B cells to plasma cells are discussed.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2495328

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  13 in total

1.  Hypomethylation of MHC class II Eb gene is associated with expression.

Authors:  T Scholl; A Pitcock; B Jones
Journal:  Immunogenetics       Date:  1992       Impact factor: 2.846

Review 2.  A family of trans-acting factors with distinct regulatory functions control expression of MHC class II genes.

Authors:  R S Accolla; P Dellabona; L Scarpellino; G Carra; S Sartoris
Journal:  Immunol Res       Date:  1990       Impact factor: 2.829

3.  CIITA stimulation of transcription factor binding to major histocompatibility complex class II and associated promoters in vivo.

Authors:  K L Wright; K C Chin; M Linhoff; C Skinner; J A Brown; J M Boss; G R Stark; J P Ting
Journal:  Proc Natl Acad Sci U S A       Date:  1998-05-26       Impact factor: 11.205

4.  Positive regulatory domain I-binding factor 1 mediates repression of the MHC class II transactivator (CIITA) type IV promoter.

Authors:  Han Chen; Carolyn A Gilbert; John A Hudson; Sophia C Bolick; Kenneth L Wright; Janet F Piskurich
Journal:  Mol Immunol       Date:  2006-06-12       Impact factor: 4.407

5.  Genetic interrogation of circulating multiple myeloma cells at single-cell resolution.

Authors:  Jens G Lohr; Sora Kim; Joshua Gould; Birgit Knoechel; Yotam Drier; Matthew J Cotton; Daniel Gray; Nicole Birrer; Bang Wong; Gavin Ha; Cheng-Zhong Zhang; Guangwu Guo; Matthew Meyerson; Andrew J Yee; Jesse S Boehm; Noopur Raje; Todd R Golub
Journal:  Sci Transl Med       Date:  2016-11-02       Impact factor: 17.956

6.  Inhibition of IL-12 production by 1,25-dihydroxyvitamin D3. Involvement of NF-kappaB downregulation in transcriptional repression of the p40 gene.

Authors:  D D'Ambrosio; M Cippitelli; M G Cocciolo; D Mazzeo; P Di Lucia; R Lang; F Sinigaglia; P Panina-Bordignon
Journal:  J Clin Invest       Date:  1998-01-01       Impact factor: 14.808

7.  Physiologic target of the Air-1 trans-activator revealed by stable transfection assay.

Authors:  S Sartoris; A De Lerma Barbaro; T Cestari; G Tridente; R S Accolla
Journal:  Immunogenetics       Date:  1994       Impact factor: 2.846

8.  2,3,7,8-Tetrachlorodibenzo-p-dioxin-mediated impairment of B cell differentiation involves dysregulation of paired box 5 (Pax5) isoform, Pax5a.

Authors:  Dina Schneider; Maria A Manzan; Robert B Crawford; Weimin Chen; Norbert E Kaminski
Journal:  J Pharmacol Exp Ther       Date:  2008-05-15       Impact factor: 4.030

9.  ZBTB32 is an early repressor of the CIITA and MHC class II gene expression during B cell differentiation to plasma cells.

Authors:  Hye Suk Yoon; Christopher D Scharer; Parimal Majumder; Carl W Davis; Royce Butler; Wendy Zinzow-Kramer; Ioanna Skountzou; Dimitrios G Koutsonanos; Rafi Ahmed; Jeremy M Boss
Journal:  J Immunol       Date:  2012-07-30       Impact factor: 5.422

10.  Developmental extinction of major histocompatibility complex class II gene expression in plasmocytes is mediated by silencing of the transactivator gene CIITA.

Authors:  P Silacci; A Mottet; V Steimle; W Reith; B Mach
Journal:  J Exp Med       Date:  1994-10-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.